Clinical Trials Directory

Trials / Conditions / Connective Tissue Disease

Connective Tissue Disease

21 registered clinical trials studyying Connective Tissue Disease — 7 currently recruiting.

StatusTrialSponsorPhase
RecruitingGanglion Resection Effectiveness Trial
NCT07162415
Tampere University HospitalN/A
Not Yet RecruitingPersonalized Outreach for Equitable Treatment in Rheumatology
NCT07022756
University of British ColumbiaN/A
RecruitingA Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis
NCT06917690
Chiesi Farmaceutici S.p.A.Phase 3
RecruitingCharacterization of "Bamboo" and Other Vocal Cord Lesions Responsible for Dysphonia in Patients With Systemic
NCT06779799
University Hospital, Brest—
RecruitingAYLo - AutoimmunitY and Loss of y
NCT06696027
University of Bonn—
RecruitingEfficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune
NCT06499233
Tongji HospitalPhase 4
RecruitingHeart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
NCT07477197
Children's Hospital Medical Center, Cincinnati—
TerminatedA Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH
NCT04084678
United TherapeuticsPhase 3
UnknownThe Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung Disease
NCT01809574
Meir Medical Center—
CompletedSafety Study of CDP7657 in Patients With Systemic Lupus Erythematosus
NCT01764594
UCB PharmaPhase 1
TerminatedOn Open-Label Study in Participants With Systemic Lupus Erythematosus
NCT01488708
Eli Lilly and CompanyPhase 3
TerminatedA Clinical Trial for CTD-ILD Treatment
NCT01424033
University of MichiganPhase 2 / Phase 3
UnknownExercise and Respiratory Therapy in Patients With Rheumatoid Arthritis / Collagenosis and Pulmonary Hypertensi
NCT00491309
Heidelberg UniversityN/A
CompletedA Study of LY2127399 in Participants With Systemic Lupus Erythematosus
NCT01205438
Eli Lilly and CompanyPhase 3
CompletedA Study of LY2127399 in Participants With Systemic Lupus Erythematosus
NCT01196091
Eli Lilly and CompanyPhase 3
CompletedAuto-immunity and Pulmonary Arterial Hypertension
NCT01208792
Assistance Publique - Hôpitaux de ParisN/A
CompletedSafety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)
NCT01093911
UCB PharmaPhase 1
CompletedA Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Scle
NCT01042158
Johns Hopkins UniversityPhase 4
UnknownEarly Diagnosis of Pulmonary Hypertension in Patients With Inflammatory Rheumatic Connective Tissue Diseases
NCT01387035
Heidelberg University—
UnknownA Study to Evaluate the Use of Bosentan in Patients With Exercise Induced Pulmonary Arterial Hypertension Asso
NCT00864201
Hamilton Health Sciences CorporationPhase 3
CompletedStudy of Heritable Connective Tissue Disorders
NCT00001641
National Human Genome Research Institute (NHGRI)—